Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroimaging of Anesthetic Modulation of Human Consciousness
NCT03361605Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Apr 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of propofol, sponsored by University of Michigan. Primary endpoint: Blood Oxygen Level Dependent Response to Sensory Stimuli at 90 minutes. Started Apr 2017; status: completed.
02
Drugs
propofol
Beyond the preview
Go deeper on NCT03361605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03361605.